Stroke Science: From Lab to Life. “As research engineers we are inspired by the challenge of enabling physicians to give patients the best possible clinical outcome.” 28 September 2022
New research shows first pass recanalization in mechanical thrombectomy could deliver environmental benefits whilst improving patient outcomes. 14 April 2022
Stroke Science: From Lab to Life. “That’s what I want to tell young women: try until you succeed. If you're really passionate about something, don't give up.” Anushree Dwivedi PhD, Research & Development Engineer, CERENOVUS 08 March 2022
Clot science: from lab to life. “I have seen the devastating impact that stroke can have – so knowing that our devices are helping people really drives me.” Sarah Johnson, PhD. 25 October 2021
New CERENOVUS study demonstrates cost-savings associated with First-Pass Effect in mechanical thrombectomy for treating acute ischemic stroke in the US and Europe 07 January 2021
First Intracranial Aneurysm Patients Treated with BRAVO Flow Diverter Following European Regulatory Approval 19 September 2018
CERENOVUS Receives European Regulatory Approval For BRAVO Flow Diverter to Treat Intracranial Aneurysms 08 August 2018
